CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory to Sales
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Supernus Pharmaceuticals inc   (NASDAQ: SUPN)
Other Ticker:  
 
 

Supernus Pharmaceuticals Inc Accounts Receivables Turnover Ratio from the forth quarter 2024 to the forth quarter 2023

Quarterly Results, Trends, Rankings, Statistics


Supernus Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the forth quarter 2024 to a ratio of 4.5, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Supernus Pharmaceuticals Inc in Dec 31 2024 quarter, has decreased to 81 days, compared to 84 days, in the Sep 30 2024 quarter.

If we take a look into Healthcare sector 219 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2024 from 1020 to 1778.

What is Receivable Turnover Ratio?
What is Supernus Pharmaceuticals Inc Selling?


What is Receivable Turnover Ratio?




SUPN Receivables Turnover Ratio (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Sep 30 2023)
III. Quarter
Y / Y Receivable Change 0.22 % 6.48 % 6.22 % -10.73 % -13.6 %
Y / Y Revenue Change 13.18 % 29.6 % 9.47 % -14.15 % -13.24 %
Receivable Turnover Ratio (TTM) 4.5 4.37 4.16 4.12 4.16
SUPN's Total Ranking # 1778 # 1020 # 1236 # 2366 #
Average receivable collection period 81 84 88 89 88
Seq. Receivable Change -2.29 % -4.65 % 3.22 % 4.21 % 3.81 %
Seq. Revenue Change -0.87 % 4.37 % 17.18 % -6.65 % 13.51 %

New: More SUPN's historic Receivables Turnover Ratios >>

Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 62
Healthcare Sector # 220
Overall Market # 1778

Receivable Turnover Ratio Statistics
High Average Low
9.44 5.22 2.77
(Sep. 30, 2014)   (Dec. 30, 2013)





SUPN Company Profile • Back to SUPN Efficiency Comparisons • Compare SUPN Receivables Turnover Ratio to its Competitors

Financial Statements
Supernus Pharmaceuticals Inc 's Accounts Receivable $ 142 Millions Visit SUPN's Balance sheet
Supernus Pharmaceuticals Inc 's Sales TTM $ 662 Millions Visit SUPN's Income Statement
Sources of SUPN's Revenues Visit SUPN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SUPN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SUPN's Growth Rates SUPN's Roa SUPN's Inventory Turnover Ratio SUPN's Dividend Comparisons
SUPN's Profitability Ratios SUPN's Roi SUPN's Asset Turnover Ratio SUPN's Dividend Growth
SUPN's Valuation Ratios SUPN's Roe SUPN's Financial Strength Ratios SUPN's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2024 Receivable at quarter ending Dec 31 2024
Teladoc Health Inc   11.97 $ 2,569.574  Millions$ 214.725  Millions
Lexicon Pharmaceuticals Inc   11.82 $ 31.081  Millions$ 2.629  Millions
Corcept Therapeutics Inc  11.79 $ 675.040  Millions$ 57.262  Millions
Integrated Biopharma Inc  11.57 $ 52.074  Millions$ 4.500  Millions
Longeveron Inc   11.13 $ 2.392  Millions$ 0.215  Millions
Myomo Inc   10.94 $ 32.185  Millions$ 2.941  Millions
Exact Sciences Corporation  10.84 $ 2,758.717  Millions$ 254.559  Millions
Option Care Health Inc   10.63 $ 4,998.202  Millions$ 470.159  Millions
Novavax inc  10.63 $ 682.162  Millions$ 64.183  Millions
National Healthcare Corp  10.43 $ 1,307.382  Millions$ 125.362  Millions
Sunlink Health Systems Inc   10.39 $ 31.927  Millions$ 3.073  Millions
Fractyl Health Inc   10.05 $ 0.093  Millions$ 0.009  Millions
Quidelortho Corp  9.95 $ 2,782.900  Millions$ 279.625  Millions
Lensar Inc   9.82 $ 53.494  Millions$ 5.447  Millions
Dih Holding Us Inc   9.79 $ 112.019  Millions$ 11.440  Millions
Inogen Inc   9.59 $ 335.705  Millions$ 35.014  Millions
Inspire Medical Systems inc   9.58 $ 801.818  Millions$ 83.715  Millions
Genedx Holdings Corp   9.45 $ 305.397  Millions$ 32.324  Millions
United Therapeutics Corporation  9.44 $ 2,877.400  Millions$ 304.775  Millions
Surmodics Inc   9.39 $ 122.773  Millions$ 13.074  Millions
Travere Therapeutics Inc   9.38 $ 233.175  Millions$ 24.871  Millions
Twist Bioscience Corporation  9.29 $ 330.189  Millions$ 35.550  Millions
Siga Technologies Inc  9.20 $ 138.719  Millions$ 15.084  Millions
Tandem Diabetes Care Inc   9.10 $ 939.574  Millions$ 103.214  Millions
Encompass Health Corporation  9.01 $ 5,373.200  Millions$ 596.050  Millions
Novocure Limited  8.93 $ 605.220  Millions$ 67.770  Millions
The Pennant Group Inc   8.89 $ 695.240  Millions$ 78.193  Millions
Enanta Pharmaceuticals Inc  8.79 $ 66.591  Millions$ 7.574  Millions
Evolus Inc   8.77 $ 371.973  Millions$ 42.428  Millions
Harmony Biosciences Holdings inc   8.72 $ 713.919  Millions$ 81.853  Millions

Date modified: 2025-02-26T17:07:35+00:00



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright � 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com